SGK1-

Shuai Leng1,2, Haijie Li1, Pengfei Zhang1

  • 1Department of Cardiac Surgery (S.L., H.L., P.Z., Z.D., B.S., S.X., Y.N., X.T., L.Z., H.W., N.L., F.Z., W.Y.), Central Hospital Affiliated to Shandong First Medical University, Jinan, China.

概括

血清和葡萄糖皮质激素调节激酶1 (SGK1) 通过促进血管光滑肌细胞 (VSMC) 转化来驱动胸前大动脉剖析 (TAD). 抑制SGK1或准SGK1-SIRT6-MMP9轴为TAD提供了一个潜在的治疗策略.